genia tagger: 242('restriction', 4)
('199', 4)
('5', 603)
('217', 4)
('168', 6)
('alleles', 5)
('49\\.7', 2)
('663', 2)
('years', 27)
('gg', 95)
('no\\.', 6)
('gt', 23)
('human', 5)
('n', 3911)
('538', 2)
('24', 30)
('current', 45)
('20', 68)
('helix-distorting', 1)
('51\\.5', 2)
('pcr', 12)
('\\?', 185)
('tt', 31)
('niel1', 3)
('table\\.', 2)
('enzyme', 3)
('bases', 7)
('4', 787)
('\\.', 2149)
('allele', 25)
('gg\\+gt', 9)
('\\*', 22)
('0\\.84\\\xe2\\\x80\\\x931\\.29', 2)
('\\(', 652)
('\\)', 653)
('1\\.27', 14)
('678', 2)
('risk', 94)
('675', 2)
('673', 2)
('sccoop', 132)
('273', 2)
('0\\.83\\\xe2\\\x80\\\x931\\.35', 2)
('1\\.02\\\xe2\\\x80\\\x931\\.65', 7)
('variants', 18)
('1\\.59\\\xe2\\\x80\\\x932\\.68', 6)
('0\\.898', 2)
('29\\.0', 2)
('45\\.1', 2)
('fpg\\/nei', 1)
('identifying', 1)
('fprp', 16)
('gender', 12)
('t4', 11)
('8\\.9', 8)
('t3', 19)
('t1', 13)
('537', 4)
('p', 1389)
('410', 88)
('t', 4402)
('-3', 12)
('299', 4)
('46\\.7', 2)
('ogg1', 2)
('291', 4)
('neil', 275)
('female', 4)
('303', 6)
('sequence', 5)
('non-genetic', 4)
('194', 11)
('22\\.3', 8)
('892', 2)
('0\\.89', 10)
('50', 29)
('9\\.5', 18)
('392', 2)
('0\\.93', 6)
('genomic', 9)
('bacterial', 1)
('polymorphic', 1)
('16\\.1', 4)
('adducts', 1)
('1\\.30', 7)
('factors', 9)
('cavity', 13)
('0\\.359', 6)
('28-bp', 2)
('version', 4)
('0\\.78\\\xe2\\\x80\\\x931\\.19', 2)
('-tcccaggtatttggtgggtagg', 2)
('fragments', 8)
('ner', 3)
('40\\.7', 6)
('multivariate', 11)
('nth1', 2)
('0\\.94', 4)
('logistic', 13)
('0\\.96', 6)
('tables', 2)
('snps', 10)
('genes', 15)
('ors', 33)
('17\\.1', 32)
('245', 2)
('51\\.9', 2)
('etiologic', 3)
('385', 2)
('243', 4)
('242', 4)
('ratio', 29)
('100', 7)
('sccoop\\.', 22)
('47\\.0', 2)
('stage', 22)
('c', 2539)
('last', 1)
('g', 1448)
('76', 40)
('177', 8)
('tumor', 39)
('products', 4)
('44\\.4', 6)
('gene', 55)
('432', 2)
('or', 679)
('software', 4)
('1\\.08', 2)
('family', 1)
('cc', 248)
('451', 6)
('21\\.0', 4)
('cg', 42)
('487', 4)
('g\\.46434077t', 13)
('2\\.06', 8)
('2\\.01', 12)
('65', 33)
('22-bp', 2)
('wild-type', 1)
('table', 37)
('47\\.4', 2)
('254', 2)
('1\\.01\\\xe2\\\x80\\\x931\\.6', 4)
('dna', 35)
('reference', 37)
('28\\.0', 2)
('1\\.02', 13)
('glycosylase', 8)
('22\\.8', 2)
('405', 2)
('28\\.1', 2)
('183', 4)
('genetic', 20)
('2', 1091)
('20\\.7', 10)
('31\\.5', 6)
('6', 552)
('31\\.9', 2)
('20\\.6', 16)
('76\\.8', 6)
('gg\\+cg', 14)
('425', 2)
('1\\.06', 10)
('15q23', 1)
('465', 2)
('759', 2)
('protect', 2)
('-tcacttcagcccaggagaccag', 2)
('99', 28)
('niehs', 2)
('p\\.pro304thr', 1)
('tg', 22)
('8p23\\.1', 1)
('former', 30)
('0\\.853', 6)
('\xc2\xa7', 12)
('19-bp', 4)
('target', 3)
('cells', 5)
('46\\.0', 2)
('0\\.76\\\xe2\\\x80\\\x931\\.17', 2)
('mammalian', 3)
('p123t', 1)
('r', 3236)
('cancers', 16)
('51\\.7', 6)
('-caacctcctgattaactggaaccaca', 2)
('ber', 22)
('male', 8)
('g\\.46438282c', 14)
('and', 481)
('322', 2)
('taq', 2)
('1\\.64\\\xe2\\\x80\\\x932\\.47', 6)
('sac', 2)
('endonuclease', 1)
('34\\.3', 4)
('site', 9)
('ii', 7)
('1\\.18', 12)
('dbsnp', 1)
('215', 6)
('1\\.11', 4)
('regression', 13)
('chromosome', 2)
('1', 1538)
('neil1', 138)
('24\\.3', 2)
('neil2', 135)
('44\\.7', 2)
('several', 4)
('24\\.9', 2)
('777', 2)
('77\\.2', 6)
('cc\\+cg', 9)
('\xe2\x80\xa1', 24)
('polymerase', 4)
('23\\.2', 2)
('snp', 16)
('802', 2)
('phase', 8)
('1\\.04', 16)
('glycosylases', 6)
('1\\.01', 8)
('cis', 7)
('\xe2\x80\x93', 267)
('neck', 6)
('51\xe2\x80\x9364', 6)
('database', 4)
('enzymes', 2)
('43\\.0', 10)
('egp', 2)
('lines', 2)
('analysis\\.', 10)
('477', 2)
('n0', 13)
('n1', 9)
('n2', 16)
('n3', 25)
('oral', 13)


spacy + metamap: 574('gt', 23)
('thermal cycler', 2)
('alleles', 5)
('ptc', 2)
('four', 14)
('gc', 18)
('primer', 4)
('integrity', 1)
('number', 8)
('eligible', 8)
('tt', 31)
('gene-environment interaction', 4)
('program', 1)
('gastric cancer', 5)
('tg', 22)
('alcohol use', 20)
('risk factors', 5)
('confirmation', 2)
('base excision repair', 1)
('risk', 94)
('frequencies', 16)
('regional', 13)
('replication', 1)
('drinking', 9)
('difference', 20)
('tri', 49)
('gg', 95)
('progression', 16)
('gender', 12)
('smoking status', 15)
('t1', 13)
('large', 7)
('small', 5)
('alcohol users', 2)
('study subject', 2)
('smaller', 1)
('cervical metastases', 2)
('findings', 15)
('trend', 2)
('direct', 1)
('recruitment', 2)
('second', 2)
('dna repair', 5)
('further', 20)
('bacterial', 1)
('errors', 1)
('power', 8)
('nei', 282)
('hae iii', 2)
('selected', 18)
('current', 45)
('version', 4)
('wilcoxon rank test', 2)
('new', 7)
('increasing', 4)
('ner', 3)
('method', 3)
('nth1', 2)
('colorectal cancer', 4)
('genotyping', 6)
('genes', 15)
('aging process', 2)
('groups', 27)
('others', 4)
('oxidative', 10)
('institutional review board', 2)
('diagnoses', 2)
('relapsed disease', 1)
('identifiable', 1)
('study', 51)
('larger', 5)
('reports', 1)
('etiology', 3)
('prior', 14)
('research studies', 2)
('diagnosed', 4)
('gene', 55)
('studies', 20)
('options', 1)
('family', 1)
('primary prevention', 1)
('defense', 2)
('decrease', 4)
('marker', 1)
('use', 61)
('dna', 35)
('probabilities', 3)
('positive', 12)
('hospital', 7)
('two', 15)
('former smokers', 7)
('alcohol drinking', 7)
('research study', 2)
('stage', 22)
('minor', 9)
('more', 39)
('informed consent form', 2)
('0\\%', 11)
('false positive', 2)
('hypopharynx', 2)
('alcoholic beverages', 2)
('upper aerodigestive tract', 2)
('odds ratios', 15)
('colon cancer', 1)
('known', 6)
('cases', 94)
('iii', 5)
('97', 116)
('logarithm', 2)
('majority', 2)
('ma', 151)
('ml', 7)
('challenge', 1)
('tc', 38)
('values', 10)
('following', 2)
('male', 8)
('example', 3)
('10\\%', 2)
('history', 6)
('control', 146)
('cancer center', 4)
('sample', 6)
('allele frequency', 1)
('study participant', 2)
('dbsnp', 1)
('advanced disease', 12)
('information', 8)
('radiation treatment', 1)
('discussion', 2)
('damage', 11)
('maps', 2)
('lesions', 2)
('adjacent', 2)
('nucleotide excision repair', 1)
('pathway', 5)
('dna damage', 3)
('map', 4)
('lesion', 2)
('minority', 2)
('variant', 26)
('blood', 6)
('snp', 16)
('date', 4)
('data', 30)
('response', 1)
('short', 2)
('egp', 2)
('cancer-free', 5)
('linkage disequilibrium', 12)
('cigarettes', 2)
('negligible', 2)
('nasopharynx', 2)
('sd', 4)
('september', 2)
('years', 27)
('stability', 3)
('same', 2)
('group', 51)
('23', 38)
('pcr', 12)
('absence', 1)
('willing', 2)
('oropharynx', 13)
('decreased', 1)
('oral cavity', 13)
('texas', 2)
('non', 32)
('diseases', 3)
('unknown origin', 2)
('fragment', 10)
('vitro', 2)
('break', 1)
('modification', 1)
('effects', 3)
('data base', 2)
('not', 219)
('association', 44)
('instructions', 2)
('restriction enzyme', 2)
('susceptibility', 4)
('term', 9)
('fprp', 16)
('university', 2)
('primary gastric cancer', 1)
('habits', 1)
('logistic regression', 13)
('metabolic syndrome', 4)
('ogg1', 2)
('mean', 12)
('subset', 2)
('status', 23)
('undetectable', 2)
('series', 4)
('thymine', 4)
('dyslipidemia', 2)
('prognosis', 2)
('frequency', 27)
('year', 34)
('alcohol', 45)
('personal history', 4)
('research', 6)
('increase', 20)
('participants', 13)
('mediated', 1)
('newly', 4)
('induced', 2)
('million', 1)
('mechanisms', 2)
('ors', 33)
('free', 5)
('effect', 5)
('standard deviation', 2)
('base', 28)
('mechanistic studies', 4)
('reference group', 5)
('r2', 4)
('methylation', 1)
('adjustment', 12)
('length', 2)
('smokers', 31)
('r-', 5)
('enzyme specificity', 1)
('major', 3)
('probability', 15)
('variables', 17)
('former alcohol drinker', 3)
('primary', 17)
('one', 17)
('liver disease', 2)
('squamous cell carcinoma', 2)
('cancer site', 3)
('genotype', 155)
('lymph nodes', 6)
('introduction', 1)
('glycosylase', 8)
('system', 1)
('approximately', 3)
('observations', 4)
('genomic dna', 6)
('molecular', 2)
('structures', 2)
('final', 2)
('basal', 1)
('white', 5)
('data collection', 2)
('target', 3)
('double', 2)
('subgroup analysis', 3)
('programs', 1)
('project', 1)
('patients', 50)
('future', 6)
('stratified', 22)
('medical care', 2)
('selection bias', 2)
('mini', 4)
('sac', 2)
('lines', 2)
('sas', 4)
('environmental health', 1)
('ethnic groups', 4)
('mim', 2)
('100\\%', 2)
('hapmap', 2)
('current smoker', 12)
('clinics', 4)
('potential', 7)
('finding', 27)
('subject', 9)
('multiple', 2)
('gastric cancers', 2)
('buffer', 2)
('regional lymph node involvement', 4)
('biologic', 4)
('significant', 52)
('phase', 8)
('class', 1)
('environmental factors', 1)
('synonym', 2)
('genetic susceptibility', 2)
('disease', 25)
('environmental exposure', 3)
('first step', 1)
('unconditional', 2)
('ipsilateral', 6)
('hospital patients', 2)
('dna glycosylases', 5)
('advanced stage', 4)
('based', 13)
('less', 12)
('mammalian cell', 3)
('triphosphate', 2)
('only', 10)
('bases', 7)
('factor', 9)
('equilibrium', 18)
('lymph node', 23)
('mixture', 4)
('frequency distribution', 15)
('fatty liver', 2)
('overall', 1)
('single nucleotide polymorphisms', 1)
('demographic feature', 2)
('reversal', 1)
('report', 17)
('untreated', 2)
('primary tumors', 6)
('logistic regression analysis', 6)
('tobacco', 3)
('ever', 60)
('tumors', 10)
('common', 12)
('activity', 5)
('cancer risk', 8)
('reference', 37)
('humans', 1)
('sex', 18)
('observed', 18)
('homozygous genotype', 3)
('individual', 3)
('result', 15)
('genomic', 9)
('polymorphic', 1)
('neil2 gene', 7)
('instance', 1)
('capacity', 2)
('odds ratio', 29)
('5-hydroxyuracil', 4)
('oxidation', 1)
('oropharyngeal cancer', 6)
('oxidize', 3)
('institution', 4)
('snps', 10)
('sequence variants', 2)
('ber', 22)
('hypothesis', 3)
('extent', 4)
('reaction', 3)
('last', 1)
('taq polymerase', 2)
('ci', 255)
('ethanol', 2)
('cancer', 58)
('drunk', 2)
('cc', 248)
('ca', 411)
('cg', 42)
('mutations', 5)
('squamous cell carcinomas', 1)
('dna repair pathway', 1)
('65', 33)
('numbers', 4)
('table', 37)
('age groups', 4)
('addition', 9)
('three', 4)
('extraction', 2)
('genetic', 20)
('statistical power', 6)
('initiation', 1)
('1 mm', 2)
('maintenance', 1)
('oropharynx cancers', 2)
('dna extraction', 2)
('allele', 25)
('smoking', 27)
('former', 30)
('present', 10)
('case', 124)
('non-hispanic', 5)
('value', 31)
('institute', 3)
('viii', 1)
('haplotypes', 26)
('31', 41)
('current drinker', 11)
('prevalence', 1)
('characteristics', 10)
('very low', 1)
('statistical analysis', 2)
('protein', 4)
('mouse', 2)
('regression', 13)
('cohort', 3)
('different', 7)
('participant', 15)
('cumulative', 1)
('radiation', 3)
('genetic variants', 2)
('elevated', 6)
('excessive', 2)
('phenotype', 2)
('units', 2)
('products', 4)
('several', 4)
('events', 2)
('development', 3)
('sequence variations', 2)
('twenty four', 2)
('nj', 2)
('kit', 2)
('persons', 2)
('purpose', 1)
('never', 14)
('statistical tests', 2)
('regional lymph node metastasis', 3)
('subgroups', 6)
('excision repair', 3)
('polymorphism', 53)
('center', 4)
('confidence intervals', 3)
('database', 4)
('analysis', 31)
('severe', 4)
('materials', 1)
('greatest', 22)
('model', 14)
('cytosine', 2)
('dimension', 20)
('subgroup', 16)
('control groups', 4)
('protocol', 2)
('sinonasal tract', 2)
('adjusted', 35)
('regional lymph nodes', 4)
('recombination repair', 1)
('50\\%', 1)
('oropharyngeal tumors', 2)
('human', 5)
('healthy control', 1)
('study population', 6)
('previous', 14)
('tables', 2)
('death', 6)
('conclusions', 1)
('r\\.', 11)
('combine', 26)
('treatment', 3)
('neil1', 138)
('antioxidant', 2)
('associations', 20)
('elevation', 4)
('increased', 19)
('loss', 6)
('survival', 3)
('possible', 5)
('experimental design', 1)
('five', 1)
('variants', 18)
('advanced', 23)
('case-control study', 5)
('mismatch repair', 1)
('either', 17)
('hepatic', 2)
('translated', 2)
('glycol', 4)
('therapeutic', 2)
('l-', 9)
('methods', 1)
('people', 1)
('histopathologic', 2)
('69', 19)
('altered', 5)
('questionnaire', 4)
('dense', 2)
('dimensions', 2)
('head and neck cancer', 6)
('lyase', 1)
('fragments', 8)
('gene expression', 2)
('genotypes', 62)
('participation', 4)
('patient', 52)
('scientific', 2)
('90\\%', 2)
('slight', 1)
('sixth', 1)
('bp', 18)
('ratios', 15)
('mgcl2', 2)
('manufacturer', 2)
('comparison', 4)
('oropharynx cancer', 2)
('lifestyle', 2)
('carcinogenesis', 2)
('new england', 2)
('statistically significant', 19)
('reactive oxygen species', 1)
('tumor', 39)
('range', 8)
('confidence interval', 7)
('software', 4)
('presence', 6)
('haplotype', 44)
('blood samples', 2)
('functional', 9)
('locus', 2)
('united states', 2)
('involvement', 6)
('female', 4)
('malignancies', 1)
('statistics', 2)
('additional', 7)
('metabolic', 8)
('fast', 2)
('clinical', 1)
('fraction', 2)
('surgical management', 1)
('combined', 24)
('function', 21)
('triton x-100', 2)
('thymine glycol', 4)
('niehs', 2)
('polymerase chain reaction', 2)
('cells', 5)
('genomic instability', 2)
('cis', 7)
('oxidative stress', 2)
('cancers', 16)
('lymph node metastasis', 5)
('polymorphisms', 38)
('distribution', 29)
('stages', 13)
('similar', 7)
('detailed', 2)
('associated', 56)
('deaths', 1)
('contralateral', 2)
('metastasis', 13)
('false positives', 2)
('evidence', 2)
('single', 7)
('men', 76)
('follow-up', 4)
('lifetime', 2)
('distributions', 23)
('tris', 2)
('pmol', 2)
('functions', 8)
('demographic variables', 2)
('nc', 302)
('percent', 8)
('incidence rate', 1)
('ng', 240)
('role', 9)
('genome', 1)
('neil2', 135)
('test', 53)
('nt', 535)
('conclusion', 3)
('node', 28)
('case-control studies', 2)
('diagnosis', 5)
('models', 4)
('mismatch', 3)
('variation', 3)
('chance', 4)
('important', 1)
('variable', 23)
('exposure', 5)
('bilateral', 2)
('genetic risk factors', 4)
('cell death', 1)
('age', 100)
('percentage', 6)
('kinetics', 1)
('n stage', 3)
('neil1 gene', 6)
('time', 9)
('n0', 13)
('n1', 9)
('n2', 16)
('n3', 25)


total: 749('gt', 23)
('thermal cycler', 2)
('alleles', 5)
('ptc', 2)
('control groups', 4)
('gg', 95)
('gc', 18)
('smoking', 27)
('1\\.30', 7)
('integrity', 1)
('increase', 20)
('number', 8)
('eligible', 8)
('tt', 31)
('gene-environment interaction', 4)
('triton x-100', 2)
('program', 1)
('gastric cancer', 5)
('tg', 22)
('alcohol use', 20)
('risk factors', 5)
('case', 124)
('confirmation', 2)
('base excision repair', 1)
('risk', 94)
('frequencies', 16)
('regional', 13)
('replication', 1)
('sccoop', 132)
('0\\.83\\\xe2\\\x80\\\x931\\.35', 2)
('ma', 151)
('drinking', 9)
('difference', 20)
('tri', 49)
('four', 14)
('progression', 16)
('gender', 12)
('t4', 11)
('t3', 19)
('smoking status', 15)
('t1', 13)
('large', 7)
('p', 1389)
('-3', 12)
('299', 4)
('small', 5)
('alcohol users', 2)
('study subject', 2)
('291', 4)
('smaller', 1)
('199', 4)
('findings', 15)
('22\\.8', 2)
('non-genetic', 4)
('194', 11)
('22\\.3', 8)
('direct', 1)
('recruitment', 2)
('second', 2)
('273', 2)
('dna repair', 5)
('further', 20)
('bacterial', 1)
('adducts', 1)
('errors', 1)
('90\\%', 2)
('nei', 282)
('hae iii', 2)
('selected', 18)
('current', 45)
('version', 4)
('wilcoxon rank test', 2)
('new', 7)
('1\\.59\\\xe2\\\x80\\\x932\\.68', 6)
('increasing', 4)
('ner', 3)
('method', 3)
('multivariate', 11)
('nth1', 2)
('colorectal cancer', 4)
('genotyping', 6)
('genes', 15)
('aging process', 2)
('statistical power', 6)
('groups', 27)
('others', 4)
('oxidative', 10)
('based', 13)
('100', 7)
('47\\.0', 2)
('20\\.6', 16)
('institutional review board', 2)
('43\\.0', 10)
('relapsed disease', 1)
('identifiable', 1)
('study', 51)
('larger', 5)
('reports', 1)
('etiology', 3)
('prior', 14)
('products', 4)
('diagnosed', 4)
('gene', 55)
('432', 2)
('options', 1)
('mechanistic studies', 4)
('family', 1)
('primary prevention', 1)
('defense', 2)
('decrease', 4)
('marker', 1)
('triphosphate', 2)
('use', 61)
('dna', 35)
('probabilities', 3)
('positive', 12)
('hospital', 7)
('only', 10)
('former smokers', 7)
('28\\.1', 2)
('28\\.0', 2)
('alcohol drinking', 7)
('research study', 2)
('6', 552)
('manufacturer', 2)
('minor', 9)
('more', 39)
('informed consent form', 2)
('0\\%', 11)
('hypopharynx', 2)
('alcoholic beverages', 2)
('upper aerodigestive tract', 2)
('odds ratios', 15)
('colon cancer', 1)
('99', 28)
('known', 6)
('cases', 94)
('iii', 5)
('97', 116)
('logarithm', 2)
('majority', 2)
('19-bp', 4)
('r2', 4)
('ml', 7)
('challenge', 1)
('0\\.76\\\xe2\\\x80\\\x931\\.17', 2)
('mammalian', 3)
('values', 10)
('following', 2)
('male', 8)
('example', 3)
('10\\%', 2)
('non-hispanic', 5)
('control', 146)
('taq', 2)
('endonuclease', 1)
('cancer center', 4)
('sample', 6)
('allele frequency', 1)
('study participant', 2)
('dbsnp', 1)
('advanced disease', 12)
('information', 8)
('radiation treatment', 1)
('discussion', 2)
('gene expression', 2)
('damage', 11)
('1', 1538)
('maps', 2)
('lesions', 2)
('adjacent', 2)
('nucleotide excision repair', 1)
('pathway', 5)
('dna damage', 3)
('map', 4)
('lesion', 2)
('minority', 2)
('variant', 26)
('polymerase', 4)
('blood', 6)
('snp', 16)
('date', 4)
('combined', 24)
('data', 30)
('response', 1)
('short', 2)
('neck', 6)
('51\xe2\x80\x9364', 6)
('enzymes', 2)
('egp', 2)
('lines', 2)
('linkage disequilibrium', 12)
('cigarettes', 2)
('negligible', 2)
('nasopharynx', 2)
('sd', 4)
('restriction', 4)
('september', 2)
('years', 27)
('stability', 3)
('same', 2)
('24', 30)
('20', 68)
('23', 38)
('pcr', 12)
('absence', 1)
('no\\.', 6)
('oropharynx', 13)
('decreased', 1)
('0\\.84\\\xe2\\\x80\\\x931\\.29', 2)
('texas', 2)
('phenotype', 2)
('non', 32)
('1\\.27', 14)
('diseases', 3)
('unknown origin', 2)
('fragment', 10)
('vitro', 2)
('break', 1)
('units', 2)
('effects', 3)
('data base', 2)
('49\\.7', 2)
('not', 219)
('locus', 2)
('association', 44)
('instructions', 2)
('restriction enzyme', 2)
('susceptibility', 4)
('term', 9)
('45\\.1', 2)
('fprp', 16)
('university', 2)
('8\\.9', 8)
('habits', 1)
('logistic regression', 13)
('oral cavity', 13)
('ogg1', 2)
('mean', 12)
('subset', 2)
('status', 23)
('neil', 275)
('undetectable', 2)
('series', 4)
('thymine', 4)
('dyslipidemia', 2)
('group', 51)
('392', 2)
('molecular', 2)
('frequency', 27)
('year', 34)
('analysis', 31)
('alcohol', 45)
('factors', 9)
('personal history', 4)
('research', 6)
('28-bp', 2)
('participants', 13)
('mediated', 1)
('newly', 4)
('induced', 2)
('million', 1)
('mechanisms', 2)
('ors', 33)
('free', 5)
('effect', 5)
('245', 2)
('standard deviation', 2)
('base', 28)
('243', 4)
('242', 4)
('reference group', 5)
('g', 1448)
('methylation', 1)
('adjustment', 12)
('length', 2)
('smokers', 31)
('r-', 5)
('enzyme specificity', 1)
('major', 3)
('probability', 15)
('451', 6)
('variables', 17)
('former alcohol drinker', 3)
('primary', 17)
('one', 17)
('16\\.1', 4)
('22-bp', 2)
('liver disease', 2)
('177', 8)
('cervical metastases', 2)
('squamous cell carcinoma', 2)
('cancer site', 3)
('1\\.01\\\xe2\\\x80\\\x931\\.6', 4)
('genotype', 155)
('lymph nodes', 6)
('introduction', 1)
('glycosylase', 8)
('system', 1)
('approximately', 3)
('regional lymph node metastasis', 3)
('183', 4)
('2', 1091)
('observations', 4)
('31\\.5', 6)
('31\\.9', 2)
('subgroups', 6)
('structures', 2)
('final', 2)
('basal', 1)
('8p23\\.1', 1)
('white', 5)
('data collection', 2)
('target', 3)
('double', 2)
('subgroup analysis', 3)
('programs', 1)
('project', 1)
('patients', 50)
('r', 3236)
('stratified', 22)
('-caacctcctgattaactggaaccaca', 2)
('ber', 22)
('selection bias', 2)
('g\\.46438282c', 14)
('and', 481)
('mini', 4)
('sac', 2)
('cancer-free', 5)
('1\\.18', 12)
('sas', 4)
('1\\.11', 4)
('environmental health', 1)
('ethnic groups', 4)
('mim', 2)
('100\\%', 2)
('hapmap', 2)
('current smoker', 12)
('322', 2)
('instance', 1)
('potential', 7)
('finding', 27)
('subject', 9)
('777', 2)
('altered', 5)
('buffer', 2)
('regional lymph node involvement', 4)
('76', 40)
('biologic', 4)
('significant', 52)
('1 mm', 2)
('phase', 8)
('glycosylases', 6)
('class', 1)
('environmental factors', 1)
('primer', 4)
('synonym', 2)
('genetic susceptibility', 2)
('disease', 25)
('wild-type', 1)
('dimension', 20)
('first step', 1)
('663', 2)
('unconditional', 2)
('ipsilateral', 6)
('hospital patients', 2)
('dna glycosylases', 5)
('advanced stage', 4)
('ratio', 29)
('helix-distorting', 1)
('less', 12)
('mammalian cell', 3)
('institution', 4)
('table\\.', 2)
('enzyme', 3)
('bases', 7)
('factor', 9)
('gg\\+gt', 9)
('equilibrium', 18)
('lymph node', 23)
('mixture', 4)
('frequency distribution', 15)
('fatty liver', 2)
('overall', 1)
('single nucleotide polymorphisms', 1)
('demographic feature', 2)
('reversal', 1)
('report', 17)
('untreated', 2)
('primary tumors', 6)
('29\\.0', 2)
('logistic regression analysis', 6)
('fpg\\/nei', 1)
('ever', 60)
('tumors', 10)
('410', 88)
('common', 12)
('logistic', 13)
('activity', 5)
('genomic dna', 6)
('cancer risk', 8)
('reference', 37)
('humans', 1)
('0\\.89', 10)
('sex', 18)
('observed', 18)
('homozygous genotype', 3)
('individual', 3)
('result', 15)
('genomic', 9)
('polymorphic', 1)
('neil2 gene', 7)
('gastric cancers', 2)
('capacity', 2)
('odds ratio', 29)
('5-hydroxyuracil', 4)
('oxidation', 1)
('future', 6)
('0\\.78\\\xe2\\\x80\\\x931\\.19', 2)
('-tcccaggtatttggtgggtagg', 2)
('oropharyngeal cancer', 6)
('40\\.7', 6)
('oxidize', 3)
('excessive', 2)
('snps', 10)
('diagnoses', 2)
('sequence variants', 2)
('medical care', 2)
('etiologic', 3)
('hypothesis', 3)
('385', 2)
('extent', 4)
('cancers', 16)
('neil1', 138)
('reaction', 3)
('c', 2539)
('last', 1)
('taq polymerase', 2)
('44\\.7', 2)
('44\\.4', 6)
('ci', 255)
('ethanol', 2)
('cancer', 58)
('drunk', 2)
('cc', 248)
('21\\.0', 4)
('cg', 42)
('mutations', 5)
('squamous cell carcinomas', 1)
('dna repair pathway', 1)
('2\\.06', 8)
('2\\.01', 12)
('65', 33)
('numbers', 4)
('table', 37)
('47\\.4', 2)
('254', 2)
('age groups', 4)
('addition', 9)
('1\\.64\\\xe2\\\x80\\\x932\\.47', 6)
('405', 2)
('extraction', 2)
('genetic', 20)
('willing', 2)
('initiation', 1)
('20\\.7', 10)
('maintenance', 1)
('oropharynx cancers', 2)
('trend', 2)
('76\\.8', 6)
('treatment', 3)
('dna extraction', 2)
('465', 2)
('protect', 2)
('168', 6)
('false positive', 2)
('former', 30)
('present', 10)
('0\\.853', 6)
('46\\.7', 2)
('46\\.0', 2)
('value', 31)
('n', 3911)
('institute', 3)
('viii', 1)
('haplotypes', 26)
('31', 41)
('current drinker', 11)
('prevalence', 1)
('characteristics', 10)
('site', 9)
('ii', 7)
('very low', 1)
('statistical analysis', 2)
('elevation', 4)
('protein', 4)
('mouse', 2)
('regression', 13)
('cohort', 3)
('different', 7)
('participant', 15)
('cumulative', 1)
('radiation', 3)
('genetic variants', 2)
('elevated', 6)
('patient', 52)
('tris', 2)
('modification', 1)
('research studies', 2)
('several', 4)
('events', 2)
('development', 3)
('892', 2)
('sequence variations', 2)
('twenty four', 2)
('nj', 2)
('kit', 2)
('persons', 2)
('23\\.2', 2)
('purpose', 1)
('1\\.08', 2)
('statistical tests', 2)
('1\\.06', 10)
('1\\.04', 16)
('experimental design', 1)
('1\\.02', 13)
('tobacco', 3)
('1\\.01', 8)
('excision repair', 3)
('polymorphism', 53)
('center', 4)
('confidence intervals', 3)
('database', 4)
('studies', 20)
('analysis\\.', 10)
('severe', 4)
('materials', 1)
('greatest', 22)
('802', 2)
('model', 14)
('cytosine', 2)
('environmental exposure', 3)
('prognosis', 2)
('subgroup', 16)
('217', 4)
('215', 6)
('protocol', 2)
('sinonasal tract', 2)
('adjusted', 35)
('regional lymph nodes', 4)
('recombination repair', 1)
('50\\%', 1)
('oropharyngeal tumors', 2)
('human', 5)
('healthy control', 1)
('study population', 6)
('previous', 14)
('tables', 2)
('death', 6)
('conclusions', 1)
('\\?', 185)
('niel1', 3)
('r\\.', 11)
('combine', 26)
('4', 787)
('\\.', 2149)
('allele', 25)
('\\*', 22)
('ca', 411)
('\\(', 652)
('\\)', 653)
('associations', 20)
('678', 2)
('increased', 19)
('loss', 6)
('675', 2)
('survival', 3)
('possible', 5)
('673', 2)
('five', 1)
('variants', 18)
('advanced', 23)
('0\\.898', 2)
('case-control study', 5)
('identifying', 1)
('24\\.9', 2)
('50', 29)
('537', 4)
('history', 6)
('mismatch repair', 1)
('t', 4402)
('hepatic', 2)
('translated', 2)
('glycol', 4)
('two', 15)
('538', 2)
('primary gastric cancer', 1)
('methods', 1)
('sequence', 5)
('metabolic', 8)
('9\\.5', 18)
('histopathologic', 2)
('69', 19)
('multiple', 2)
('questionnaire', 4)
('dense', 2)
('dimensions', 2)
('head and neck cancer', 6)
('cavity', 13)
('0\\.359', 6)
('lyase', 1)
('fragments', 8)
('425', 2)
('genotypes', 62)
('participation', 4)
('either', 17)
('0\\.93', 6)
('0\\.94', 4)
('scientific', 2)
('0\\.96', 6)
('slight', 1)
('sixth', 1)
('303', 6)
('17\\.1', 32)
('bp', 18)
('ratios', 15)
('mgcl2', 2)
('stage', 22)
('comparison', 4)
('oropharynx cancer', 2)
('lifestyle', 2)
('carcinogenesis', 2)
('new england', 2)
('statistically significant', 19)
('reactive oxygen species', 1)
('metabolic syndrome', 4)
('tumor', 39)
('range', 8)
('confidence interval', 7)
('therapeutic', 2)
('or', 679)
('software', 4)
('presence', 6)
('haplotype', 44)
('blood samples', 2)
('functional', 9)
('three', 4)
('united states', 2)
('variable', 23)
('g\\.46434077t', 13)
('involvement', 6)
('female', 4)
('antioxidant', 2)
('malignancies', 1)
('statistics', 2)
('additional', 7)
('people', 1)
('fast', 2)
('clinical', 1)
('fraction', 2)
('surgical management', 1)
('gg\\+cg', 14)
('function', 21)
('15q23', 1)
('clinics', 4)
('759', 2)
('cc\\+cg', 9)
('thymine glycol', 4)
('-tcacttcagcccaggagaccag', 2)
('niehs', 2)
('polymerase chain reaction', 2)
('role', 9)
('never', 14)
('\xc2\xa7', 12)
('1\\.02\\\xe2\\\x80\\\x931\\.65', 7)
('cells', 5)
('genomic instability', 2)
('cis', 7)
('p123t', 1)
('oxidative stress', 2)
('51\\.5', 2)
('lymph node metastasis', 5)
('51\\.7', 6)
('51\\.9', 2)
('polymorphisms', 38)
('distribution', 29)
('stages', 13)
('similar', 7)
('detailed', 2)
('associated', 56)
('deaths', 1)
('contralateral', 2)
('34\\.3', 4)
('metastasis', 13)
('false positives', 2)
('evidence', 2)
('single', 7)
('men', 76)
('follow-up', 4)
('lifetime', 2)
('distributions', 23)
('chromosome', 2)
('pmol', 2)
('functions', 8)
('demographic variables', 2)
('l-', 9)
('nc', 302)
('percent', 8)
('tc', 38)
('incidence rate', 1)
('ng', 240)
('power', 8)
('5', 603)
('genome', 1)
('24\\.3', 2)
('neil2', 135)
('test', 53)
('nt', 535)
('conclusion', 3)
('node', 28)
('case-control studies', 2)
('diagnosis', 5)
('77\\.2', 6)
('models', 4)
('mismatch', 3)
('variation', 3)
('sccoop\\.', 22)
('\xe2\x80\xa1', 24)
('chance', 4)
('important', 1)
('n1', 9)
('487', 4)
('exposure', 5)
('\xe2\x80\x93', 267)
('bilateral', 2)
('genetic risk factors', 4)
('cell death', 1)
('age', 100)
('percentage', 6)
('kinetics', 1)
('n stage', 3)
('477', 2)
('neil1 gene', 6)
('time', 9)
('n0', 13)
('p\\.pro304thr', 1)
('n2', 16)
('n3', 25)
('oral', 13)
